Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
China NT Pharma Group Co., Ltd. ( (HK:1011) ) just unveiled an announcement.
China NT Pharma Group Co., Ltd. has announced a change in its executive leadership with Mr. Ng Tit stepping down as CEO to focus on strategic development, while remaining as Chairman of the Board. Mr. Zhang Bozhi, an experienced professional in the pharmaceutical industry with a background in sales and management, has been appointed as the new CEO, bringing his expertise to drive the company’s business development and strategic planning.
More about China NT Pharma Group Co., Ltd.
China NT Pharma Group Co., Ltd. is a company in the pharmaceutical industry, focusing on the development and distribution of pharmaceutical products. The company is known for its strategic market focus and has been expanding its business operations.
Average Trading Volume: 1,331,087
Technical Sentiment Signal: Hold
Current Market Cap: HK$256.2M
Learn more about 1011 stock on TipRanks’ Stock Analysis page.